BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.83 Cr | ₹-1.41 Cr | ₹-1.20 Cr | ₹-0.68 Cr | ₹-0.65 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BETA DRUGS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.83 Cr |
| Mar2024 | ₹-1.41 Cr |
| Mar2023 | ₹-1.20 Cr |
| Mar2022 | ₹-0.68 Cr |
| Mar2021 | ₹-0.65 Cr |
How is Deferred Tax Assets / Liabilities of BETA DRUGS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.83 Cr | Negative | |
| Mar2024 | ₹-1.41 Cr | Negative | |
| Mar2023 | ₹-1.20 Cr | Negative | |
| Mar2022 | ₹-0.68 Cr | Negative | |
| Mar2021 | ₹-0.65 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,329.6 Cr | 1.2% | -7.2% | 13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.2% |
-7.2% |
13.9% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses